Neurocrine

Ação

ISIN: US64125C1099

Ticker: NBIX

US64125C1099

NBIX

Price

Discussão sobre NBIX

Postos

But T.

@But_the_Stock_Picked_Me

2Mês·

$NBIX (+0,04%)
$REGN (-0,27%) Is there anyone here who is invested in Neurocrine or Regeneron?

The shares seem to be attractively priced at the moment and the companies appear to be financially sound. However, I'm not that familiar with the sector yet.

I would therefore be grateful for any opinions.

10 Comentários

Memo0606@Memo0606

2Mês

buy NOW after exaggerated sell-off
numbers were good

•

DJJD

@DJJOSE

6Mês·

$NBIX (+0,04%)

Neurocrine Biosciences (NASDAQ:NBIX) said the FDA has accepted its two new drug applications for priority review for its drug crinecerfont in the treatment of pediatric and adult patients with congenital adrenal hyperplasia, a rare endocrine disorder.

https://seekingalpha.com/news/4121247-fda-sets-target-action-dates-for-neurocrine-drug-applications

Títulos em alta

Principais criadores desta semana